- Home
- NFJ vs AMPH Comparison
NFJ vs AMPH Comparison
Compare NFJ & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFJ
- AMPH
- Stock Information
- Founded
- NFJ 2005
- AMPH 1996
- Country
- NFJ United States
- AMPH United States
- Employees
- NFJ N/A
- AMPH N/A
- Industry
- NFJ Finance: Consumer Services
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- NFJ Finance
- AMPH Health Care
- Exchange
- NFJ Nasdaq
- AMPH Nasdaq
- Market Cap
- NFJ 1.2B
- AMPH 1.1B
- IPO Year
- NFJ N/A
- AMPH 2014
- Fundamental
- Price
- NFJ $12.50
- AMPH $21.21
- Analyst Decision
- NFJ
- AMPH Hold
- Analyst Count
- NFJ 0
- AMPH 5
- Target Price
- NFJ N/A
- AMPH $38.00
- AVG Volume (30 Days)
- NFJ 223.5K
- AMPH 476.8K
- Earning Date
- NFJ 01-01-0001
- AMPH 08-07-2025
- Dividend Yield
- NFJ 9.01%
- AMPH N/A
- EPS Growth
- NFJ N/A
- AMPH N/A
- EPS
- NFJ N/A
- AMPH 2.77
- Revenue
- NFJ N/A
- AMPH $730,659,000.00
- Revenue This Year
- NFJ N/A
- AMPH $0.92
- Revenue Next Year
- NFJ N/A
- AMPH $5.55
- P/E Ratio
- NFJ N/A
- AMPH $7.67
- Revenue Growth
- NFJ N/A
- AMPH 8.05
- 52 Week Low
- NFJ $10.45
- AMPH $20.39
- 52 Week High
- NFJ $12.86
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- NFJ 46.63
- AMPH 39.13
- Support Level
- NFJ $12.64
- AMPH $20.43
- Resistance Level
- NFJ $12.90
- AMPH $22.90
- Average True Range (ATR)
- NFJ 0.15
- AMPH 0.74
- MACD
- NFJ -0.03
- AMPH 0.05
- Stochastic Oscillator
- NFJ 14.89
- AMPH 32.80
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.